Noninvasix
PrivateLast Round
Reverse Merger
Dec 16, 2025
Total Funding Raised
$3.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Noninvasix is a medical device company developing a non-invasive patient monitoring system using patented optoacoustic technology to measure organ oxygenation, with initial applications in neonatal care and sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noninvasix Comparables
Compare Noninvasix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GE HealthCare Technologies Inc. | 74% | |
| Medtronic | 72% | |
| Baxter International Inc | 71% | |
Noninvasix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Dec 16, 2025 | ||||
| Private Placement | Oct 30, 2025 | ||||
| Seed | Feb 4, 2021 | ||||
| Seed | Jan 7, 2019 |
Key People
Founding team and executive leadership
Noninvasix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Philips Ventures | Seed, Accelerator |
| Athenian Capital | Seed |
| NIH RADx | Grant |
| The Catalyst Fund | Seed |
| Texas Medical Center Venture Fund | Seed |
| Cypher Metaverse Inc. | Reverse Merger |
| Green Park & Golf Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
$3M raised from Cypher Metaverse Inc.
- Oct 30, 2025
$3M raised in a private placement round.
Noninvasix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Noninvasix's valuation, stock price, and market status.